NervGen Pharma Corp. (NGEN)
3.565
-0.14
(-3.91%)
USD |
NASDAQ |
May 15, 16:00
3.63
+0.06
(+1.82%)
After-Hours: 20:00
NervGen Pharma Free Cash Flow : -17.09M for March 31, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| CannaPharmaRx, Inc. | -0.7891M |
| Lexaria Bioscience Corp. | -9.470M |
| InMed Pharmaceuticals, Inc. | -7.710M |
| Target Group, Inc. (Canada) | -0.4808M |
| Tilray Brands, Inc. | -75.96M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -5.978M |
| Cash from Investing (Quarterly) | 0.0061M |
| Cash from Financing (Quarterly) | 2.026M |
| Free Cash Flow Per Share (Quarterly) | -0.0748 |
| Free Cash Flow to Equity (Quarterly) | -5.972M |
| Free Cash Flow to Firm (Quarterly) | -5.978M |
| Free Cash Flow Yield | -6.35% |